Caribou Biosciences, Inc. (CRBU) Revenue Growth
Caribou Biosciences, Inc. (CRBU) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 44.31% |
| 2023-12-31 | 148.91% |
| 2024-12-31 | -71.01% |
| 2025-12-31 | 11.66% |
How CRBU compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| NTLA | Intellia Therapeutics Inc. | 16.92% |
| MOH | Molina Healthcare Inc | 11.75% |
| VNDA | Vanda Pharmaceuticals Inc. | 8.72% |
| BKD | Brookdale Senior Living Inc. | 2.19% |
| MYGN | Myriad Genetics Inc. | -1.56% |
These are five companies in the same sector as CRBU with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Caribou Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("CRBU", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CRBU | $1.57 | +0.00% | 1.33M |
| 3 | ||||
| 4 | ||||
| 5 |